tiprankstipranks
Biocryst Pharmaceuticals (BCRX)
NASDAQ:BCRX
US Market

BioCryst (BCRX) Income Statement

Compare
2,225 Followers

BioCryst Income Statement

Last quarter (Q4 2024), BioCryst's total revenue was $131.53M, an increase of 40.83% from the same quarter last year. In Q4, BioCryst's net income was $-26.80M. See BioCryst’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 450.71M$ 331.41M$ 270.83M$ 157.17M$ 17.81M
Gross Profit
$ 438.44M$ 326.75M$ 264.23M$ 149.91M$ 16.14M
Operating Expenses
$ 440.99M$ 430.46M$ 412.67M$ 327.63M$ 190.89M
Depreciation and Amortization
$ 1.25M$ 1.66M$ 1.44M$ 777.00K$ 748.00K
EBITDA
$ 12.81M$ -116.33M$ -143.85M$ -121.74M$ -167.56M
Operating Income
$ -2.54M$ -103.71M$ -148.44M$ -177.72M$ -174.76M
Other Income/Expenses
$ -84.41M$ -122.52M$ -95.95M$ -4.09M$ -8.06M
Pretax Income
$ -86.95M$ -226.23M$ -244.38M$ -181.81M$ -182.81M
Net Income
$ -88.88M$ -226.54M$ -247.12M$ -184.06M$ -196.57M
Per Share Metrics
Basic EPS
$ -0.43$ -1.18$ -1.33$ -1.03$ -1.18
Diluted EPS
$ -0.43$ -1.18$ -1.33$ -1.03$ -1.18
Weighted Average Shares Outstanding
206.70M 192.20M 185.91M 179.12M 167.27M
Weighted Average Shares Outstanding (Diluted)
206.70M 192.20M 185.91M 179.12M 167.27M
Currency in USD

BioCryst Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis